BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16412817)

  • 1. Causes of hyperhomocysteinemia in patients with chronic kidney diseases.
    Garibotto G; Sofia A; Valli A; Tarroni A; Di Martino M; Cappelli V; Aloisi F; Procopio V
    Semin Nephrol; 2006 Jan; 26(1):3-7. PubMed ID: 16412817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine and methionine metabolism in renal failure.
    van Guldener C; Stehouwer CD
    Semin Vasc Med; 2005 May; 5(2):201-8. PubMed ID: 16047272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of hyperhomocysteinemia in chronic kidney disease.
    Massy ZA
    Semin Nephrol; 2006 Jan; 26(1):24-7. PubMed ID: 16412821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration in the redox state of plasma in heart-transplant patients with moderate hyperhomocysteinemia.
    Di Giuseppe D; Di Simplicio P; Capecchi PL; Lazzerini PE; Pasini FL
    J Lab Clin Med; 2003 Jul; 142(1):21-8. PubMed ID: 12878982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperhomocysteinemia in chronic renal failure.].
    Satta E; Perna AF; Lombardi C; Acanfora F; Violetti E; Romano MM; Capasso R; Pisano M; Paduano F; De Santo NG
    G Ital Nefrol; 2006; 23(5):480-9. PubMed ID: 17123261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine.
    Stam F; van Guldener C; ter Wee PM; Kulik W; Smith DE; Jakobs C; Stehouwer CD; de Meer K
    Am J Physiol Renal Physiol; 2004 Aug; 287(2):F215-23. PubMed ID: 15271686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients.
    Herrmann W; Obeid R
    Clin Chem Lab Med; 2005; 43(10):1039-47. PubMed ID: 16197295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
    Jakubowski H
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure.
    Bernasconi AR; Liste A; Del Pino N; Rosa Diez GJ; Heguilén RM
    Nephrology (Carlton); 2006 Apr; 11(2):137-41. PubMed ID: 16669976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols.
    Di Giuseppe D; Frosali S; Priora R; Di Simplicio FC; Buonocore G; Cellesi C; Capecchi PL; Pasini FL; Lazzerini PE; Jakubowski H; Di Simplicio P
    J Lab Clin Med; 2004 Nov; 144(5):235-45. PubMed ID: 15570241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of a HPLC method for simultaneous quantitation of plasma homocysteine and cysteine.
    Atamasirikul K; Kajanachumpol S; Wilairat P; Tantibhedhyangkul P
    J Med Assoc Thai; 2008 Mar; 91(3):338-44. PubMed ID: 18575286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic consequences of hyperhomocysteinemia in uremia.
    Perna AF; Ingrosso D; Satta E; Romano M; Cimmino A; Galletti P; Zappia V; De Santo NG
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S85-90. PubMed ID: 11576929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of transmethylation disturbs neurulation in chick embryos.
    Afman LA; Blom HJ; Drittij MJ; Brouns MR; van Straaten HW
    Brain Res Dev Brain Res; 2005 Aug; 158(1-2):59-65. PubMed ID: 15996755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between plasma S-adenosylhomocysteine concentration and glomerular filtration rate in children.
    Jabs K; Koury MJ; Dupont WD; Wagner C
    Metabolism; 2006 Feb; 55(2):252-7. PubMed ID: 16423634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteinemia correlates with plasma thiol redox status in patients with end-stage renal disease.
    Palleschi S; De Angelis S; Rossi B; Diana L; Papa V; Severini G; Splendiani G
    Nephron Clin Pract; 2008; 108(2):c106-12. PubMed ID: 18212512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
    Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
    J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced pertubation of the aminothiol redox-status in patients with epilepsy: improvement by B-vitamins.
    Apeland T; Frøyland ES; Kristensen O; Strandjord RE; Mansoor MA
    Epilepsy Res; 2008 Nov; 82(1):1-6. PubMed ID: 18644700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.